Invent Biotechnology

Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: ELISA

Description: Stainless Steel 100-Cell, 13-Shelf Inventory Rack (ea.) for 10K, 24K, 38K, LABS 20K, LABS 38K, LABS 40K, LABS 80K

Description: Inverted Transfer Cap for 2L High Efficiency Erlenmeyer Flask ,TPE Tube (50cm 1/8" ID 1/4" OD), Heat seal,Vent Filter (0.22 μm 13.8cm²),Sterile, 1/pk, 4/cs

Description: Inverted Transfer Cap for 2L High Efficiency Erlenmeyer Flask ,TPE Tube ( 50cm 1/4" ID 7/16" OD), Heat seal,Vent Filter (0.22 μm 13.8cm²), Sterile, 1/pk, 4/cs

Description: Inverted Transfer Cap for 3L High Efficiency Erlenmeyer Flask,TPE Tube (50cm 1/8" ID 1/4" OD), Heat seal ,Vent Filter (0.22 μm 13.8cm²), Sterile, 1/pk, 4/cs

Description: Inverted Transfer Cap for 3L High Efficiency Erlenmeyer Flask,TPE Tube ( 50cm 1/4" ID 7/16" OD), Heat seal ,Vent Filter (0.22 μm 13.8cm²), Sterile, 1/pk, 4/cs

Description: Inverted Transfer Cap for 5L High Efficiency Erlenmeyer Flask,TPE Tube (90cm 1/8" ID 1/4" OD), Heat seal,Vent Filter (0.22 μm 13.8cm²) , Sterile, 1/pk, 4/cs

Description: Inverted Transfer Cap for 5L High Efficiency Erlenmeyer Flask,TPE Tube ( 90cm 1/4" ID 7/16" OD), Heat seal,Vent Filter (0.22 μm 13.8cm²) , Sterile, 1/pk, 4/cs

Description: Inverted Transfer Cap for 3L Wide-Mouth High Efficiency Erlenmeyer Flask ,TPE Tube (50cm 1/8" ID 1/4" OD), Heat seal,Vent Filter (0.22 μm 13.8cm²), Sterile, 1/pk, 4/cs

Description: Inverted Transfer Cap for 3L Wide-Mouth High Efficiency Erlenmeyer Flask ,TPE Tube (50cm 1/4" ID 7/16" OD), Heat seal,Vent Filter (0.22 μm 13.8cm²), Sterile, 1/pk, 4/cs

Description: Biotin-Ova (323-339) is the N-ter biotinylated version of Ova (323-339). Biotin-Ova (323-339) can be used in the analysis of antigen-specific T cells. Ovalbumin protein: Ova (323-339) is an epitope of interest of the egg white albumen, which is widely used in allergy research. Ovalbumin is a glycoprotein that is sufficiently large and complex to be mildly immunogenic. Indeed, it has been demonstrated that Ovalbumin contains B-cell epitopes which are recognized by specific IgE antibodies and CD4 T cell epitopes restricted by the MHC I-Ad molecule in mice and by HLA-D molecule in human.Applications of Ova (323-339):Ova (323-339) allows to study bindings of class II MHC-peptide and T-cell activation in PBMCs by ELISPOT assays. In fact, this method quantifies peptide epitope specificity and IFN-γ releasing effector cells. It has been shown that Ova (323-339) was responsible for 25-35% of T-cell response of isolated BALB/c mouse. An investigation has demonstrated that Ova and Ova (323-339) induced similar lung inflammation and a Th2-like dominant immune response in mouse model. Sequence: Biotin-ISQAVHAAHAEINEAGR

Description: Biotin-FluM1 (58-66) is the N-ter biotinylated version of FluM1 (58-66). Biotin-FluM1 (58-66) can be used in the analysis of antigen-specific T cells.FluM1 (58-66):FluM1 (58-66) is a short part of the matrix protein of Influenza A virus which is the most abundant component of this enveloped virus localized under the viral lipid envelope. The GILGFVFTL epitope is highly conserved in Influenza A virus strains at a rate of 93% for 69 strains tested. Human Influenza epitopes may bind MHC molecules and then may be recognized by CD8+ cytotoxic T cells. Applications of FluM1 (58-66):FluM1 (58-66) is used to stimulate CTL responses in peripheral blood mononuclear cells (PBMCs). Then, ELISPOT assay is used to quantify peptide epitope specificity and IFN-γ releasing effector cells.FluM1 (58-66) has shown CTL responses qualified of immunodominant with restriction by HLA-A*02:01. It has also been detected CTL responses when FluM1 (58-66) is restricted by all HLA-C. Therefore, FluM1 (58-66) may help to understand the reaction of immune system against Influenza virus of each populations having different HLA type.FluM1 (58-66) has indeed prompted research to develop T-cell vaccine strategies capable of inducing specific CTL responses in patients upon immunization with Influenza M1 antigenic epitope. MVA-NP+M1 vaccine use GILGFVFTL epitope and is tested in clinical trial.Potential cross-reactivity with HIV-1 p17 Gag (77-85):Moreover, FluM1 (58-66) share similarities with HIV-1 p17 Gag (77-85) which can potentially show a cross-reactivity between these epitopes. It has been demonstrated a cross-reactivity and results suggest that immunity following infection by Influenza virus causes specific immune response to HIV-1 p17 Gag (77-85).Sequence: Biotin-GILGFVFTL

Description: Pan HLA DR-binding epitope (PADRE) is a universal peptide that activates CD4+ T cells which can be used as an agonist adjuvant.

Description: Biotin-MAGE-A1 (278-286) is the N-ter biotinylated version of MAGE-A1 (278-286). Biotin-MAGE-A1 (278-286) can be used in the analysis of antigen-specific T cells. MAGE-A1 protein:MAGE-A1 (278-286) is an epitope of Melanoma Antigen Gene A1 expressed by tumors of different histological types such as on the surface of breast carcinoma cell and is a Cancer/Testis Antigens (CTA). MAGE-A1 is a tumor antigen expressed in 40% of melanoma and contains epitope for binding HLA-A*02:01 molecules and that are recognized by cytotoxic T cells. Applications of MAGE-A1 (278-286): MAGE-A1 (278-286) is used to stimulate specific cytotoxic T cells in PBMCs and to analyze by ELISPOT peptide epitope specificity and cytokine production like IFN-γ. Immunogenicity of MAGE-A1 (278-286) raised the possibility of developing anticancer immunotherapies or vaccinations. MAGE-A1 is also expressed in lung adenocarcinoma and studies suggest that MAGE-A1 may serve to develop Chimeric Antigen Receptor (CAR) T cell therapy using lentiviral vector and show an encouraging tumor-inhibitory efficacy.Sequence: Biotin-KVLEYVIKV